DiaSorin Company Description

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally.

It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name.

The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens.

In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay.

Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.

DiaSorin S.p.A.

Country	Italy
Founded	1968
Industry	Diagnostics & Research
Sector	Healthcare
Employees	3,308
CEO	Carlo Rosa

Contact Details

Address: Via Crescentino snc Saluggia, Vercelli 13040 Italy
Phone	39 016 1487526
Website	int.diasorin.com

Stock Details

Ticker Symbol	DIA
Exchange	Borsa Italiana
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	IT0003492391
SIC Code	2835

Key Executives

Name	Position
Carlo Rosa	Chief Executive Officer, GM and Executive Director
Dr. Chen Menachem Even	Chief Commercial Officer, Senior Corporate Vice President of Commercial Operations and Executive Director
Piergiorgio Pedron	Senior Corporate Vice President, Chief Financial Officer and Corporate Accounting Documents Officer
Dr. Riccardo Fava	Corporate Vice President of Communication, ESG and Investor Relations
Ulisse Spada	Corporate Vice President, Head of the Legal Department, Secretary and General Counsel
Amelia Parente	Senior Corporate Vice President of Human Resources
Angelo Rago	President of Luminex Corporation